Recent Quotes (30 days)

You have no recent quotes
chg | %

AstraZeneca plc news

   Watch this stock
Showing stories 1 - 10 of about 39   

Articles published

AZN 4,954.55 -56.45 (-1.13%)
price chart
Apple, Google, Oracle, AstraZeneca: Intellectual Property
AstraZeneca Plc, the U.K.'s second-biggest drugmaker, shouldn't get a further reduction in an antitrust fine of 52.5 million euros ($67.5 million), an adviser to the European Union's highest court said.
Boards wake up to a shareholder spring
Two weeks ago David Brennan, chief executive of AstraZeneca, bowed to pressure from the pharmaceutical group's top shareholders and stepped down at the annual meeting.
GSK rejects idea of buying AstraZeneca
L) has no interest in buying smaller rival AstraZeneca (AZN.L), GSK's chief executive said on Thursday in response to a shareholder question at the company's annual meeting.
UBM investors revolt over executive pay
The shareholder rebellion follows similar protests over pay at Trinity Mirror, Barclays, Aviva and AstraZeneca and comes as the Department of Business, Innovation and Skills is consulting on executive remuneration and shareholder rights.
US to Seek New Uses for Abandoned Drugs
But researchers and the university or hospital involved will get patent rights for any new uses of the compound, according to the NIH and drug-company officials.
Moss quits after pay revolt at Aviva
Mr Moss is the third high-profile UK chief executive to fall victim to investor anger, following the departures of Sly Bailey from Trinity Mirror and David Brennan from AstraZeneca. But the terms of Mr Moss's exit drew criticism after Aviva last week ...
UK Pay Protests Oust Aviva Chief  Wall Street Journal
Aviva Chief Executive Officer Andrew Moss to Leave  Bloomberg
Abbott to Pay $1.6 Billion to Settle Depakote Drug Allegations
Pfizer Inc. agreed to buy an antibiotics business from AstraZeneca Plc for $725 million as well as other payouts, seeking to add to its pipeline of treatments intended to fight infections.
Abbott to pay $1.6 billion for Depakote marketing  Reuters
Where can investors find shelter from the volatility storm?
Similarly, AstraZeneca fell by 665p but it is yielding a very attractive 6.5pc. Mr McDermott tipped Neil Woodford's Invesco Perpetual High Income fund but said equities were not the only route to income.
Drug-Defying Germs From India Speed Post-Antibiotic Era
... Bush, a microbiologist at Indiana University in Bloomington. She led teams that developed five bacteria-fighting drugs beginning in the 1970s in laboratories that are now part of AstraZeneca Plc, Bristol-Myers Squibb Co., Johnson & Johnson and ...
Glaxo Diabetes Drug Data Revealed Amid Hostile Takeover
... in January and currently the only once-weekly treatment for Type 2 diabetes on the market. Amylin, like Human Genome, has lured suitors for a takeover, including Pfizer Inc., AstraZeneca Plc and Merck & Co., people familiar with the matter said ...